BeOne Medicines And Max Foundation Renew Partnership To Expand Access To BRUKINSA For The Treatment Of Chronic Lymphocytic Leukemia Through 2028

뉴스 본문을 불러오고 있어요.

BeOne Medicines And Max Foundation Renew Partnership To Expand Access To BRUKINSA For The Treatment Of Chronic Lymphocytic Leukemia Through 2028 | 웨이프 WAPE

BeOne Medicines And Max Foundation Renew Partnership To Expand Access To BRUKINSA For The Treatment Of Chronic Lymphocytic Leukemia Through 2028

기사 요약

관련 종목

댓글 —